Interleukin-13 (IL-13) is a key anti-inflammatory and regulatory cytokine associated with T-helper 2 (Th2) immune responses. Produced mainly by Th2 cells, mast cells, basophils, and type 2 innate lymphoid cells (ILC2s), IL-13 plays a central role in allergic reactions, airway inflammation, tissue repair, and mucosal immunity. It works closely with IL-4, sharing many overlapping functions that shape the body’s defense against parasites and modulate chronic inflammation.
Biological Function
IL-13 helps coordinate the body’s transition from active inflammation to tissue healing and immune regulation. Its primary functions include:
-
Promoting B-cell activation and antibody (IgE) production, enhancing allergic and parasite defenses
-
Regulating mucus secretion and airway responsiveness in respiratory tissues
-
Inhibiting pro-inflammatory cytokines like IL-1β, TNF-α, and IFN-γ to limit tissue damage
-
Encouraging wound healing and fibrosis through fibroblast activation and collagen synthesis
-
Maintaining mucosal barrier integrity in the lungs and intestines
IL-13 helps maintain a balance between inflammation and tissue restoration, but when persistently elevated, it can contribute to fibrotic and allergic disease processes.
Elevated IL-13 Levels
High IL-13 levels are often associated with Th2-dominant immune activity, where antibody and allergic responses outweigh cell-mediated defenses. Chronic IL-13 elevation can drive mucus overproduction, fibrosis, and airway hypersensitivity.
Common associations with elevated IL-13 include:
-
Allergic and atopic conditions such as asthma, allergic rhinitis, eczema, and food allergies
-
Eosinophilic inflammation, including eosinophilic esophagitis (EoE) and allergic airway disease
-
Parasitic infections, which naturally induce IL-13 as part of the immune defense
-
Fibrotic disorders, such as idiopathic pulmonary fibrosis or liver fibrosis, where IL-13 promotes tissue remodeling
-
Chronic inflammatory states, including metabolic inflammation and neuroimmune dysregulation
In these cases, elevated IL-13 can reflect an overactive Th2 response, contributing to chronic allergic inflammation, airway obstruction, or tissue scarring.
Low IL-13 Levels
Low IL-13 levels may suggest insufficient anti-inflammatory or Th2 activity, leading to a dominance of Th1- or Th17-driven inflammation. This imbalance is often linked to autoimmune conditions, chronic inflammatory syndromes, or poor tissue healing. Deficient IL-13 may also reduce mucosal barrier protection, increasing susceptibility to infections and inflammation at epithelial surfaces.
IL-13 in the Cytokine Response Profile (CytoDx)
Within the Cytokine Response Profile (CytoDx) by Diagnostic Solutions Laboratory, IL-13 is measured as part of the anti-inflammatory cytokine panel, alongside IL-4, IL-5, and IL-10. Together, these markers reflect Th2 immune balance and the body’s ability to regulate or counteract pro-inflammatory activity (Th1/Th17).
A high IL-13 level indicates a Th2-skewed immune response, often seen in allergies or fibrotic conditions, while low IL-13 can signify an inflammatory bias toward Th1 or Th17 dominance. Analyzing IL-13 alongside other cytokines helps clinicians identify whether the immune system is promoting resolution and repair or remains in a pro-inflammatory state.
Clinical Insights
-
High IL-13: Suggests Th2 dominance; often linked to allergies, asthma, or fibrotic inflammation.
-
Low IL-13: Indicates insufficient anti-inflammatory activity or Th1/Th17 imbalance.
-
Balanced IL-13: Reflects effective immune regulation and resolution of inflammation.
Supporting Healthy IL-13 Balance
To promote balanced IL-13 activity and overall immune homeostasis, strategies may include:
-
Managing allergic triggers and reducing exposure to environmental irritants
-
Anti-inflammatory nutrition: omega-3s, antioxidants, and polyphenols such as curcumin and quercetin
-
Gut and respiratory health support, as mucosal balance influences IL-13 production
-
Stress management and adequate sleep, which help maintain optimal cytokine regulation
-
Addressing chronic inflammation or infection, to prevent persistent Th2 activation
Summary
IL-13 (Interleukin-13) is an anti-inflammatory Th2 cytokine that regulates immune tolerance, supports tissue repair, and contributes to allergic and fibrotic processes. Elevated IL-13 levels are linked to asthma, eczema, and fibrosis, while low levels may reflect insufficient immune regulation and increased inflammatory risk. Within the Cytokine Response Profile (CytoDx) by Diagnostic Solutions Laboratory, IL-13 provides valuable insight into Th2 immune function, helping clinicians assess whether inflammation is balanced, allergic, or dysregulated.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.